{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:16:55Z","timestamp":1791944215152,"version":"4.3.4"},"reference-count":19,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background: Liver disease linked to the hepatitis B virus (HBV) is a serious public threat worldwide and in Egypt. The incidence of HBV infection in Egypt is about 1.4%. Accurate liver fibrosis assessments are crucial in the evaluation and follow-up of HBV patients, but traditional biopsies have limitations, prompting the use of non-invasive methods like the vibration controlled transient elastography (VCTE), which may not be available in limited-resource treatment centers.  Objective: This study aimed to assess the diagnostic accuracy of Fibrosis-4 (FIB-4) and Aminotransferase to Platelet Ratio Index (APRI) compared to VCTE in detecting significant liver fibrosis in adult chronic HBV patients, potentially offering a more accessible and less costly approach to disease management. Methods - In this cross-sectional study, 247 subjects with chronic HBV from Alexandria University Viral Hepatitis Treatment Unit were included. Data collected included demographic details, HBV viral load, liver function tests, Complete Blood Count (CBC), international normalized ratio (INR), prothrombin time, albumin, total and direct bilirubin, APRI score, FIB-4 score, imaging, and VCTE data. IBM SPSS software was used for statistical analysis, with qualitative and quantitative data described appropriately. Logistic regression and receiver operating characteristic curve (ROC) curves were used to identify significant predictors of advanced fibrosis and assess diagnostic performance.  Results: Based on VCTE results, 247 chronic hepatitis B patients were classified into two groups: 140 with no or mild fibrosis (F0\/1) and 107 with significant fibrosis (F2-F4). Significant differences were found in hemoglobin, albumin, and INR levels between the groups. The FIB-4 and APRI scores were significantly higher in the significant fibrosis group, with median FIB-4 scores of 1.26 vs 0.79 and median APRI scores of 0.40 vs 0.27. The FIB-4 index remained a significant predictor of significant fibrosis in multivariate analysis, with an odds ratio of 1.558. At a cut-off value of &gt;0.88, the FIB-4 score achieved a sensitivity of 65.42% and a specificity of 60.0% in differentiating patients with and without significant fibrosis.  Conclusion: Although the use of FIB-4 score is potentially useful in resource-limited settings, a significant number of misclassifications can occur due to its moderate sensitivity and specificity which necessitate further incorporation of additional diagnostic methods to ensure the accurate staging of liver fibrosis.<\/jats:p>","DOI":"10.1590\/s0004-2803.24612025-085","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:24:06Z","timestamp":1784546646000},"source":"Crossref","is-referenced-by-count":1,"title":["LIMITED DIAGNOSTIC ACCURACY OF FIB-4 FOR DETECTING SIGNIFICANT LIVER FIBROSIS IN CHRONIC HEPATITIS B: A CROSS-SECTIONAL STUDY"],"prefix":"10.1590","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1519-5428","authenticated-orcid":false,"given":"Elyas Abdullah","family":"ALSALAMY","sequence":"first","affiliation":[{"name":"Alexandria University-Manchester University,  Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7516-2763","authenticated-orcid":false,"given":"Heba Mahmoud Taha","family":"ELWESHAHI","sequence":"additional","affiliation":[{"name":"Alexandria University,  Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9921-5583","authenticated-orcid":false,"given":"Heba Hany","family":"OMAR","sequence":"additional","affiliation":[{"name":"Alexandria University,  Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0957-0977","authenticated-orcid":false,"given":"Ahmed","family":"KAMAL","sequence":"additional","affiliation":[{"name":"Alexandria University,  Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/v16050724","article-title":"Hepatitis B Virus Infection: A Mini Review","volume":"16","author":"Asandem DA","year":"2024","journal-title":"Viruses"},{"key":"ref2","first-page":"14","article-title":"Hepatitis B virus in Egypt: the whole story","author":"Abdelhamed W","year":"2024","journal-title":"Egypt Liver J"},{"key":"ref3","first-page":"00174","article-title":"EASL Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"S0168-8278","year":"2025","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S2468-1253(24)00089-X","article-title":"WHO 2024 hepatitis B guidelines: an opportunity to transform care","volume":"9","author":"Easterbrook PJ","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault NA","year":"2018","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000116","article-title":"Safety and yield of percutaneous liver biopsy in adults and children with chronic hepatitis B: Results from a prospective, multicenter study","volume":"7","author":"Ghany MG","year":"2023","journal-title":"Hepatol Commun"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3390\/jcm13041046","article-title":"Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients","volume":"13","author":"Bera C","year":"2024","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"100067","DOI":"10.1016\/j.jhepr.2020.100067","article-title":"Limitations of non-invasive tests for assessment of liver fibrosis","volume":"2","author":"Patel K","year":"2020","journal-title":"JHEP Rep"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S2468-1253(19)30087-1","article-title":"Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study","volume":"4","author":"Sonneveld MJ","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref10","article-title":"A Comparative Analysis of the APRI, FIB4, and FibroScan Score in Evaluating the Severity of Chronic Liver Disease in Chronic Hepatitis B Patients in India","volume":"13","author":"Rungta S","year":"2021","journal-title":"Cureus"},{"key":"ref11","first-page":"3406789","article-title":"Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis","volume":"2018","author":"Qi X","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1478-3231.2008.01802.x","article-title":"Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B","volume":"29","author":"Marcellin P","year":"2009","journal-title":"Liver Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"22944","DOI":"10.18632\/oncotarget.14430","article-title":"Diagnostic value of FIB-4 for liver fibrosis in patients with hepatitis B: a meta-analysis of diagnostic test","volume":"8","author":"Yin Z","year":"2017","journal-title":"Oncotarget"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00535-021-01782-3","article-title":"Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis","volume":"56","author":"Itakura J","year":"2021","journal-title":"J Gastroenterol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.36519\/idcm.2023.276","article-title":"How Successful Are APRI and FIB-4 Scores in Predicting Liver Fibrosis in Chronic Hepatitis B Patients?","volume":"5","author":"G\u00fcr-Altunay D","year":"2023","journal-title":"Infect Dis Clin Microbiol"},{"key":"ref16","first-page":"368","article-title":"Clinical Application of Vibration Controlled Transient Elastography in Patients with Chronic Hepatitis B","volume":"5","author":"Liang XE","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3390\/diagnostics14131317","article-title":"Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis","volume":"14","author":"Tamaki N","year":"2024","journal-title":"Diagnostics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/jvh.12161","article-title":"Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection","volume":"21","author":"Trembling PM","year":"2014","journal-title":"J Viral Hepat"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/jvh.14004","article-title":"Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Antiviral Treatment","volume":"31","author":"Liang LY","year":"2024","journal-title":"J Viral Hepat"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["Precis\u00e3o diagn\u00f3stica limitada do FIB-4 para a dete\u00e7\u00e3o de fibrose hep\u00e1tica significativa na hepatite B cr\u00f4nica: um estudo transversal"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032026000101404&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:24:10Z","timestamp":1784546650000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032026000101404&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":19,"alternative-id":["S0004-28032026000101404"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.24612025-085","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e25085"}}